Livzon Pharmaceutical Group Inc. (HKG:1513)

HKG:1513 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Jan 1, 2021
Market Capitalization	31,932	32,675	31,168	31,039	39,657	39,381
Market Cap Growth	4.57%	4.83%	0.41%	-21.73%	0.70%	27.23%
Enterprise Value	25,456	26,363	25,008	25,207	33,283	32,171
Last Close Price	29.22	26.54	21.94	22.34	22.84	23.17
PE Ratio	13.64	14.90	14.48	14.38	18.19	19.33
PS Ratio	2.47	2.60	2.28	2.17	2.68	3.15
PB Ratio	1.90	2.06	1.92	1.84	2.26	2.43
P/TBV Ratio	2.19	2.30	2.10	2.08	2.56	2.82
P/FCF Ratio	11.52	12.75	11.65	14.98	54.46	21.90
P/OCF Ratio	9.14	10.31	8.71	9.90	16.98	15.35
EV/Sales Ratio	1.90	2.10	1.83	1.77	2.25	2.58
EV/EBITDA Ratio	7.78	8.03	8.28	8.70	11.58	11.19
EV/EBIT Ratio	8.91	9.77	11.81	11.54	14.14	13.35
EV/FCF Ratio	9.18	10.29	9.35	12.17	45.71	17.89
Debt / Equity Ratio	0.26	0.27	0.28	0.24	0.19	0.14
Debt / EBITDA Ratio	1.36	1.28	1.50	1.40	1.14	0.80
Debt / FCF Ratio	1.55	1.65	1.71	1.98	4.54	1.27
Asset Turnover	0.48	0.48	0.50	0.54	0.56	0.55
Inventory Turnover	2.31	2.09	2.33	2.47	2.74	2.82
Quick Ratio	1.95	1.87	1.86	1.97	1.83	2.13
Current Ratio	2.25	2.15	2.13	2.30	2.12	2.40
Return on Equity (ROE)	16.43%	15.53%	12.78%	13.37%	13.97%	16.45%
Return on Assets (ROA)	6.38%	6.40%	4.81%	5.11%	5.58%	6.58%
Return on Invested Capital (ROIC)	26.24%	26.92%	19.70%	20.64%	25.12%	33.56%
Return on Capital Employed (ROCE)	14.70%	15.10%	11.30%	11.10%	12.40%	14.00%
Earnings Yield	7.33%	6.71%	6.91%	6.95%	5.50%	5.17%
FCF Yield	8.68%	7.85%	8.58%	6.67%	1.84%	4.57%
Dividend Yield	4.09%	4.41%	6.78%	8.09%	6.99%	6.41%
Payout Ratio	48.57%	65.03%	81.36%	83.33%	70.81%	64.14%
Buyback Yield / Dilution	2.91%	1.10%	0.56%	0.04%	0.25%	-0.41%
Total Shareholder Return	7.00%	5.51%	7.34%	8.13%	7.23%	6.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.